DWK-1339

DWK-1339

CAT N°: 27642
Price:

From 182.00 154.70

DWK-1339 is an inhibitor of amyloid-? (A?) aggregation.{35159} It inhibits aggregation of monomeric A? (1-42) (A?42) and induces disaggregation of A?42 fibrils in vitro when used at concentrations ranging from 3.1 to 50 µM. DWK-1339 (10 µM) reduces A?42-induced toxicity in HT-22 cells. In vivo, DWK-1339 (10 mg/kg) increases step-through latency in a passive avoidance test and increases spontaneous alteration in the Y-maze compared with vehicle control mice in a mouse model of A?42-induced acute Alzheimer’s disease. It also decreases brain levels of A?42 and increases spontaneous alteration in the Y-maze in the APP/PS1 transgenic mouse model of Alzheimer’s disease.

We also advise you

TAF 10 Peptide

TAF 10 Peptide

TAF10 is one of many protein factors or coactivators associated with RNA polymerase II activity.{16903} One vial of this peptide...

€191.00
View